Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure : JAIDS Journal of Acquired Immune Deficiency Syndromes

Secondary Logo

Journal Logo

Prevention Research

Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure

Mayer, Kenneth H. MDa,b,c; Gelman, Marcy NPa; Holmes, Johnathon NPa; Kraft, Jessica NPa; Melbourne, Kathleen PharmDd; Mimiaga, Matthew J. ScD, MPHa,e

Author Information
JAIDS Journal of Acquired Immune Deficiency Syndromes 90(1):p 27-32, May 1, 2022. | DOI: 10.1097/QAI.0000000000002912

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid